Latest news
Artrya (ASX:AYA) Moves From FDA Clearances to US Hospital Adoption - kalkine.com.aukalkine.com.au · Mon, 10 Aug 2026 02:19:00 GMTEli Lilly Locks In Retatrutide FDA Filing Date — Can the Stock Climb to $1,750 by 2027? - NAI500NAI500 · Sat, 08 Aug 2026 02:03:05 GMTAmid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - The Cancer LetterThe Cancer Letter · Fri, 07 Aug 2026 20:50:43 GMTXenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 18:02:12 GMTFDA's Overhaul of Food Ingredient Safety Review Clears the White House, Setting Up a Rule Decades in the Making - Medical DailyMedical Daily · Thu, 06 Aug 2026 14:30:07 GMTModerna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock - BioSpaceBioSpace · Thu, 06 Aug 2026 11:52:35 GMT15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training - Stock TitanStock Titan · Wed, 05 Aug 2026 12:30:00 GMTFDA’s Draft MDUFA VI Commitment Letter: What It Means for AI and Digital Health - bipartisanpolicy.orgbipartisanpolicy.org · Wed, 05 Aug 2026 00:47:26 GMT